The Zeke Cancer Fund

This research proposes to use a vaccine that investigators have extensive experience with in canine melanoma and bone cancer (osteosarcoma). New preliminary research indicates that the vaccine target, GD3, is present in HSA, similar to melanoma and osteosarcoma use. All dogs will get standard-of-care treatment and randomized into two groups - one getting the GD3-based vaccine and the other group receiving placebo. Since melanoma and osteosarcoma have shown promising results, investigators hope that dogs with HSA respond similarly to the vaccine.

Liposomal Cancer Vaccine Clinical Trial for Canine Hemangiosarcoma

The Golden Retriever Foundation® is a Gold Sponsor of Morris Animal Foundation’s Golden Retriever Lifetime Study. The Study is one of the largest, most comprehensive prospective canine health studies in the United States. The Study’s purpose is to identify the nutritional, environmental, lifestyle and genetic risk factors for cancer and other diseases in dogs. Each year, with the help of veterinarians and dog owners, the Foundation collects health, environmental and behavioral data on 3,000+ enrolled golden retrievers.

• More Information on the Golden Retriever Lifetime Study
• Latest Golden Retriever Lifetime Study Report
• More information on Morris Animal Foundation studies supported by the Golden Retrieiver Foundation
• Visit the Morris Animal Foundation

Golden Retrievers develop an eye condition that practitioners should know about – Golden Retriever Pigmentary Uveitis (GRPU). This condition has an insidious onset, but early detection can be a key to avoiding glaucoma and vision loss.  Wendy Townsend DVM, MS, DACVO provides helpful information to help everyone better understand this condition.

The webinar will be available for viewing for 2 years at: Golden Retriever Pigmentary Uveitis

Watch the webinar and learn about risk factors, how to recognize signs of GRPU on an ocular examination, keys to making a clinical diagnosis, treatment options, and breeding advice.

Running time: 53 mins plus 11 mins of Q&A

The Golden Retriever Foundation ® provided the funding to make this webinar available to anyone interested and for veterinarians and veterinary technicians to obtain 1 hour of CE credit by AAVSB RACE, NY State, and the NJVMA for veterinarians and veterinary technicians

The Golden Retriever Foundation® actively seeks opportunities to fund health studies that further the understanding of diseases, genetic defects, injuries and other ailments that afflict dogs in general and Golden Retrievers in particular. Since its inception, the GRF has awarded health related grants exceeding a total of $3,500,000. By working with the Canine Health Foundation and the Morris Animal Foundation, expenses are often shared with other breed clubs that have a vested interest in similar health issues.

The funding process begins in the hands of research scientists when they apply directly to the CHF or MAF for financial support in the form of grants. Once one of these organizations approves a proposal through their own rigorous process, those that focus on Goldens or diseases that affect our breed may be forwarded to the Golden Retriever Foundation® for funding consideration. The GRF relies on the expert advice and counsel of the GRCA’s Health and Genetics Committee, chaired by Ann Hubbs, DVM, PhD. This committee evaluates the proposal and summarizes its strengths and weaknesses based on several criteria, including relevance to Golden Retrievers, strength of the preliminary data, abilities of the researchers and quality of the facilities, scientific approach, and the strength of the hypothesis. Based heavily upon the committee’s recommendations, GRF completes the process by approving or declining funds to support the grant.